Abstract

In South Korea, domestic cattle, pigs, and goats were subjected to mandatory foot-and-mouth disease (FMD) vaccination and year-round serosurveillance since 2011. In 2020, approximately USD 95 million was spent solely for FMD vaccine purchase for 59 million livestock, and 1.25 million samples were tested to estimate the population immunity and demonstrate the absence of virus circulation. As the FMD vaccination program was revised in 2018, the post-vaccination monitoring (PVM) was designed to evaluate the effectiveness of the vaccine program of three vaccines approved for routine use. To this end, monitoring post-vaccination immunity has been conducted by collecting 35,626 serum samples at 28 days post-vaccination following regular national vaccinations, which were carried out in April and in October in 2020. The design of the serological test for PVM was specially targeted at particular livestock groups, including dairy cattle, goats, and beef cattle aged 6–12 months, which were generally estimated to have a low expected seroprevalence. The risk factors had also been identified, considering the increased likelihood of infection in a particular location, herd size, and husbandry system applied in a targeted sample collection. Serum sample collection and SP-O and NSP antibody tests were performed by local veterinary laboratories using commercially available ELISAs. The current FMD vaccination program, which was performed twice a year following the regimen of primary vaccination and boost, resulted in over 80% population immunity. The seroprevalence monitored after the vaccination in fall was higher than the one studied in spring except in pigs. It was demonstrated that the seroprevalence of risk-based targeted samples ranged from 93.8 to 100% in cattle, 63.2 to 100% in pigs, and 20.0 to 100% in goats. Of note is the area near the North Korean borders which showed a relatively low seroprevalence among the targeted regions, and no NSP sero-positive reactor was detected in this region. When subpopulation immunity at the individual level was assessed, the seroprevalence in young cattle stock was slightly lower (95.8%) than that of adults (98.4%). In conclusion, the FMD vaccination campaign has been successfully implemented in Korea, and the PVM can be a supplementary program for massive routine surveillance in terms of providing timely information needed both to estimate population immunity and to properly target “risk-based surveillance.”

Highlights

  • Post-vaccination monitoring (PVM) to evaluate the performance of vaccination regimens and program is essential for those countries embarking in vaccine-based foot-and-mouth disease (FMD) control policy [1,2,3,4,5,6]

  • There was a total of 31,642 serum samples collected from 2,385 farms in nine provinces across the country at 1 month after the first round and second round of vaccination in May and November, respectively

  • The results of the clinical examination of the presence of FMD symptoms, conducted during blood collection, and NSP antibody ELISA indicated that there was no infection in the field

Read more

Summary

Introduction

Post-vaccination monitoring (PVM) to evaluate the performance of vaccination regimens and program is essential for those countries embarking in vaccine-based foot-and-mouth disease (FMD) control policy [1,2,3,4,5,6]. Along with the implementation of FMD vaccines, a massive year-round serological surveillance program has been launched in 2011 to search the evidence of FMD virus (FMDV) circulation and evaluate population immunity. The massive routine FMD serosurveillance, abiding by the national year-round surveillance program, provides valuable information on FMDV circulation in the field and population immunity by vaccination [16, 17]. In this regard, 637,292 and 637,593 of serum samples were subjected to SP and NSP antibody ELISA, respectively, in 2020 (the national serosurveillance monthly report is available to the public at www.qia.go.kr). The collected serosurveillance data were further analyzed at various subpopulation levels to evaluate the vaccineinduced immunity in high-risk groups

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.